Vertex Pharmaceuticals Just Made a Major Move: Is the Stock a Buy?
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Plan a withdrawal strategy post-rebalancing for SP 500 holdings to sustain income while managing risk.
24,074 articlesVertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
Jim Cramer challenges a fresh downgrade on Apple, arguing the stock’s AI ambitions and a possible 2027 supercycle jus...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
Salesforce heads into a pivotal Q4 showing whether Agentforce can convert hype into durable revenue. A strong read co...
C3.ai saw a sharp drop after its latest results, renewing debate about whether the stock is a value play or a value t...
Analysts kicked off the week with a wave of fresh calls on major names, signaling a mixed tone across consumer, tech ...
A landmark court ruling opens a path for refunds on tariffs. Americans demanding refunds from tariffs are turning to ...
A major fund recently added a huge stake in Neptune Insurance Holdings, boosting the quarter-end position by over $65...
After years of outsized gains, the magnificent seven faces a pullback. This guide explains how to evaluate the dip, p...
Uber reports a landmark milestone as Uber One membership tops 50 million, with members driving half of Mobility and D...
Praxis (Prax) 2026 earnings signals a path from solid growth to stronger profitability. This analysis breaks down the...